Verastem, Inc. Available-for-sale Securities, Amortized Cost Basis
Verastem, Inc. (VSTM) had Available-for-sale Securities, Amortized Cost Basis of $8.99 million as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2017-11-07
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $8.99M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $30.34M.
- 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $44.38M.
- 2016-12-31: Available-for-sale Securities, Amortized Cost Basis $48.52M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2017-09-30 | $8.99M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $30.34M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $44.38M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $48.52M 10-Q · filed 2017-11-07 | |
| 2016-09-30 | $49.55M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $53.23M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $84.25M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $85.34M 10-K · filed 2017-03-23 | |
| 2015-09-30 | $100.59M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $96.89M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $105.91M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $58.76M 10-K · filed 2016-03-03 | |
| 2014-09-30 | $72.78M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $81.93M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $100.61M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $104.74M 10-K · filed 2015-03-10 | |
| 2013-09-30 | $107.55M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $64.13M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $56.15M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $81.40M 10-K · filed 2014-03-06 | $81.40M 10-K · filed 2013-03-26 |
| 2012-09-30 | $86.28M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $88.55M 10-Q · filed 2012-08-13 | |
| 2011-12-31 | $35.85M 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |